Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immuneering Corp shares valued at $20,020 were purchased by Hall Brett Matthew on Jun 20 ’25. At $2.70 per share, Hall Brett Matthew acquired 7,415 shares. The insider’s holdings grew to 353,311 shares worth approximately $1.07 million following the completion of this transaction.
Also, Hall Brett Matthew purchased 6,007 shares, netting a total of over 14,596 in proceeds. Following the buying of shares at $2.43 each, the insider now holds 359,318 shares.
Before that, Brakewood Harold Eugene had added 1,900 shares to its account. In a trade valued at $4,804, the Chief Business Officer bought Immuneering Corp shares for $2.53 each. Upon closing the transaction, the insider’s holdings increased to 1,900 shares, worth approximately $17516.0.
As published in a research note from Morgan Stanley on December 13, 2024, Immuneering Corp [IMRX] has been rated down from an Equal-weight to an Underweight. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in mid March. As of March 15, 2024, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for IMRX. Earlier on March 15, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for IMRX stock which previously was a “a Buy”.
Analyzing IMRX Stock Performance
On last trading session,, Immuneering Corp [NASDAQ: IMRX] rose 2.72% to $3.02. The stock’s lowest price that day was $2.87, but it reached a high of $3.24 in the same session. During the last five days, there has been a surge of approximately 65.93%. Over the course of the year, Immuneering Corp shares have jumped approximately 111.19%. Shares of the company reached a 52-week high of $3.80 on 01/07/25 and a 52-week low of $1.10 on 05/12/25.
Support And Resistance Levels for Immuneering Corp (IMRX)
According to the 24-hour chart, there is a support level at 2.85, which, if violated, would cause prices to drop to 2.67. In the upper region, resistance lies at 3.22. The next price resistance is at 3.41. RSI (Relative Strength Index) is 67.66 on the 14-day chart, showing neutral technical sentiment.
Is Immuneering Corp subject to short interest?
Stocks of Immuneering Corp saw a sharp rise in short interest on 2025-05-30 jumping by 58469.0 shares to 0.92 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.87 million shares. A jump of 6.32% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.47 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.47.
Which companies own the most shares of Immuneering Corp (IMRX)?
In terms of Immuneering Corp share price expectations, FactSet research, analysts set an average price target of 13 in the next 12 months, up nearly 342.18% from the previous closing price of $2.94. Analysts anticipate Immuneering Corp stock to reach 41 by 2025, with the lowest price target being 3. In spite of this, 3 analysts ranked Immuneering Corp stock as Buy at the end of 2025. On December 01, 2023, Needham assigned a price target of “a Buy” to the stock and initiated coverage with a $20.
